nach oben

Erschienen in:

16.09.2022 | Koronare Herzerkrankung | CME

Management des chronischen Koronarsyndroms

verfasst von: Udo Sechtem, Andreas Seitz, Peter Ong, Raffi Bekeredjian

Erschienen in: Herz | Ausgabe 5/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Die koronare Herzkrankheit ist immer noch die häufigste Todesursache in den Industrieländern. Dieser CME-Artikel greift wichtige Punkte aus den aktuellen Leitlinien zum chronischen Koronarsyndrom der European Society of Cardiology (ESC) bzw. zum Brustschmerz der American Heart Association (AHA)/des American College of Cardiology (ACC) auf und kommentiert sie.

Statista (2022) Häufigste Todesursachen in Ländern mit hohem und niedrigem Einkommen im Jahr 2016. https://de.statista.com/statistik/daten/studie/990596/umfrage/todesursachen-in-laendern-mit-hohem-und-niedrigem-einkommen/. Zugegriffen: 9. Juli 2022

Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407–477. https://doi.org/10.1093/eurheartj/ehz425CrossRefPubMed

Saraste A, Knuuti J (2020) ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: recommendations for cardiovascular imaging. Herz 45:409–420. https://doi.org/10.1007/s00059-020-04935-xCrossRefPubMedPubMedCentral

Writing Committee Members, Gulati M, Levy PD et al (2021) 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 78:e187–e285. https://doi.org/10.1016/j.jacc.2021.07.053CrossRef

Joseph A, Ackerman D, Talley JD et al (1993) Manifestations of coronary atherosclerosis in young trauma victims—an autopsy study. J Am Coll Cardiol 22:459–467CrossRef

Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37:267–315. https://doi.org/10.1093/eurheartj/ehv320CrossRefPubMed

Collet JP, Thiele H, Barbato E et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42:1289–1367. https://doi.org/10.1093/eurheartj/ehaa575CrossRefPubMed

Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003. https://doi.org/10.1093/eurheartj/eht296CrossRefPubMed

Bairey Merz CN, Pepine CJ, Walsh MN et al (2017) Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation 135:1075–1092. https://doi.org/10.1161/CIRCULATIONAHA.116.024534CrossRefPubMed

10.

Kunadian V, Chieffo A, Camici PG et al (2020) An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation. Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 41:3504–3520. https://doi.org/10.1093/eurheartj/ehaa503CrossRefPubMedPubMedCentral

11.

Ong P, Athanasiadis A, Perne A et al (2014) Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis. Clin Res Cardiol 103:11–19. https://doi.org/10.1007/s00392-013-0615-9CrossRefPubMed

12.

Foldyna B, Udelson JE, Karady J et al (2018) Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jey182CrossRefPubMedCentral

13.

Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42:3227–3337. https://doi.org/10.1093/eurheartj/ehab484CrossRefPubMed

14.

Winther S, Schmidt SE, Mayrhofer T et al (2020) Incorporating coronary calcification into pre-test assessment of the likelihood of coronary artery disease. J Am Coll Cardiol 76:2421–2432. https://doi.org/10.1016/j.jacc.2020.09.585CrossRefPubMed

15.

Lee KK, Wereski R, Williams MC et al (2021) Population screening with coronary computed tomography angiography and the prevention of coronary events. Circulation 144:930–933. https://doi.org/10.1161/CIRCULATIONAHA.121.055784CrossRefPubMed

16.

Greenwood JP, Ripley DP, Berry C et al (2016) Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA 316:1051–1060. https://doi.org/10.1001/jama.2016.12680CrossRefPubMed

17.

Lauer MS, Pothier CE, Magid DJ et al (2007) An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram. Ann Intern Med 147:821–828. https://doi.org/10.7326/0003-4819-147-12-200712180-00001CrossRefPubMed

18.

Shaw LJ, Berman DS, Picard MH et al (2014) Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging 7:593–604. https://doi.org/10.1016/j.jcmg.2013.10.021CrossRefPubMedPubMedCentral

19.

Dewey M, Rief M, Martus P et al (2016) Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial. BMJ 355:i5441. https://doi.org/10.1136/bmj.i5441CrossRefPubMedPubMedCentral

20.

Chang HJ, Lin FY, Gebow D et al (2019) Selective referral using CCTA versus direct referral for individuals referred to invasive coronary angiography for suspected CAD: a randomized, controlled, open-label trial. JACC Cardiovasc Imaging 12:1303–1312. https://doi.org/10.1016/j.jcmg.2018.09.018CrossRefPubMed

21.

Group DT, Maurovich-Horvat P, Bosserdt M et al (2022) CT or invasive coronary angiography in stable chest pain. N Engl J Med 386:1591–1602. https://doi.org/10.1056/NEJMoa2200963CrossRef

22.

Nagel E, Greenwood JP, McCann GP et al (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. N Engl J Med 380:2418–2428. https://doi.org/10.1056/NEJMoa1716734CrossRefPubMed

23.

De Bruyne B, Fearon WF, Pijls NH et al (2014) Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371:1208–1217. https://doi.org/10.1056/NEJMoa1408758CrossRefPubMed

24.

Xaplanteris P, Fournier S, Pijls NHJ et al (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379:250–259. https://doi.org/10.1056/NEJMoa1803538CrossRefPubMed

25.

Hachamovitch R (2015) Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease effectively identifies revascularization candidates. Circ Cardiovasc Imaging 8:e352. https://doi.org/10.1161/CIRCIMAGING.113.000352CrossRefPubMed

26.

Maron DJ, Hochman JS, Reynolds HR et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395–1407. https://doi.org/10.1056/NEJMoa1915922CrossRefPubMedPubMedCentral

27.

Mark DB, Spertus JA, Bigelow R et al (2022) Comprehensive quality-of-life outcomes with invasive versus conservative management of chronic coronary disease in ISCHEMIA. Circulation 145:1294–1307. https://doi.org/10.1161/CIRCULATIONAHA.121.057363CrossRefPubMed

28.

Patel KK (2022) Improving symptoms and quality of life in stable coronary artery disease: an evolving paradigm. Circulation 145:1308–1311. https://doi.org/10.1161/CIRCULATIONAHA.122.059482CrossRefPubMed

29.

Vermeltfoort IA, Raijmakers PG, Odekerken DA et al (2009) Association between anxiety disorder and the extent of ischemia observed in cardiac syndrome X. J Nucl Cardiol 16:405–410. https://doi.org/10.1007/s12350-008-9032-2CrossRefPubMed

30.

Jespersen L, Hvelplund A, Abildstrom SZ et al (2012) Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33:734–744. https://doi.org/10.1093/eurheartj/ehr331CrossRefPubMed

31.

Patel KH, Doodnauth AV, Dunkley JC et al (2021) Aborted sudden cardiac death from vasospastic-induced ventricular fibrillation with normal coronary angiography: a case report and review of the literature. Am J Med Case Rep 9:78–82. https://doi.org/10.12691/ajmcr-9-1-20CrossRefPubMed

32.

Ong P, Athanasiadis A, Sechtem U (2016) Intracoronary acetylcholine provocation testing for assessment of coronary vasomotor disorders. J Vis Exp. https://doi.org/10.3791/54295CrossRefPubMedPubMedCentral

33.

Yilmaz A, Hill S, Schaufele T et al (2010) Exercise-induced spastic coronary artery occlusion at the site of a moderate stenosis: neither Prinzmetal’s angina nor cardiac syndrome X but “Prinzmetal X”. Circulation 122:e570–e574. https://doi.org/10.1161/CIRCULATIONAHA.110.984823CrossRefPubMed

34.

Taqueti VR, Hachamovitch R, Murthy VL et al (2015) Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131:19–27. https://doi.org/10.1161/CIRCULATIONAHA.114.011939CrossRefPubMed

35.

Knott KD, Seraphim A, Augusto JB et al (2020) The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping. Circulation 141:1282–1291. https://doi.org/10.1161/CIRCULATIONAHA.119.044666CrossRefPubMedPubMedCentral

36.

Feenstra RGT, Seitz A, Boerhout CKM et al (2022) Principles and pitfalls in coronary vasomotor function testing. EuroIntervention 17:1271–1280. https://doi.org/10.4244/EIJ-D-21-00402CrossRefPubMed

37.

Grundy SM, Stone NJ, Bailey AL et al (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 73:e285–e350. https://doi.org/10.1016/j.jacc.2018.11.003CrossRefPubMed

Titel: Management des chronischen Koronarsyndroms
verfasst von: Udo Sechtem
Andreas Seitz
Peter Ong
Raffi Bekeredjian
Publikationsdatum: 16.09.2022
Verlag: Springer Medizin
Schlagwörter: Koronare Herzerkrankung
KHK in der Hausarztpraxis
Thoraxschmerzen
Diagnostik in der Kardiologie
Erschienen in: Herz / Ausgabe 5/2022
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-022-05137-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Management des chronischen Koronarsyndroms

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin

Klimawandel und Gesundheit: Was Sie in der Hausarztpraxis wissen müssen und tun können

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2022

Erratum to: Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic

Lipidsenkung: neue Substanzen und neue Konzepte

First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study

Assessment of proarrhythmic ventricular electrophysiological remodeling in patients with rheumatoid arthritis

Treatment of heart failure with preserved ejection fraction with SGLT2 inhibitors: new therapy standard?

Rhythmologische und metabolische Kontrolle

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

Vorsicht, erhöhte Blutungsgefahr nach PCI!

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

Update Innere Medizin